Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

Medibank Private Ltd (MPL) Dividend Rises As Revenue Creeps Higher

Medibank Private Ltd (ASX:MPL) shareholders will be paid a 7.2 cents final dividend after the leading private health insurer released its 2018 financial results.

Medibank Private Ltd (ASX:MPL) shareholders will be paid a 7.2 cent final dividend after the leading private health insurer released its 2018 financial results. Together with its interim dividend earlier in the year, Medibank’s total dividends rose 5.8% to 12.7 cents.

In a statement to the ASX on Friday, Medibank revealed a 1.6% increase in revenue and a profit of $445 million, down 1% on its 2017 result.

According to data from Bloomberg, analysts had been expecting Medibank to report a profit of $461 million and pay dividends of 12.8 cents per share. Therefore, it appears Medibank’s profit was slightly below expectations.

Investment Income Down, Market Share Up

Medibank said its revenue from insurance premiums rose 1.2% while investment income fell 31%.

“The progress in our company is pleasing,” Medibank CEO Craig Drummond said. “We are now positioned for growth with a focus on leveraging our dual brands, building competitive advantage in health insurance and transforming into a broader health services company.”

In addition to more Aussies opting out of private cover due to the rising costs of health insurance, Medibank has had its fair share of customers leaving on account of being dissatisfied with coverage, service and prices. Fortunately, Drummond said that trend appears to be on the mend.

“The highlight for the year has been a substantial turnaround in customer advocacy and retention, driven by consistently delivering a better customer experience, more value and recognising customer loyalty,” Drummond noted.

Adding, “These improvements have seen market share grow 5 basis points over the past 6 months. This is the first time in a decade we have experienced growth over a 6-month period.”

More to come?

In the year ahead Medibank is again targeting modest growth in its market share while producing cost savings of up to $60 million between 2018 and 2020.

Since the government sold Medibank to investors in 2014 its share price has risen from $2.10 to $3.17 today, according to Google Finance.

The Australian Investors Podcast

The Australian Investors Podcast provides insights from Australia’s best investors, entrepreneurs, authors and financial thinkers. Download the latest episode free on iTunesCastboxYouTube or wherever you choose to listen.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Skip to content